Back to search
FDAFDA · Food and drugs·Recall number D-0018-2025

Vancomycin HCl 750 mg per 250 mL 0.9% Sodium Chloride Injection USP, Single Dose Bag, Rx only, Fagron Sterile Services, Canton, MA NDC 71506-014-58

Published October 30, 2024 · Recall initiated: September 25, 2024

Summary

FDA records drug Class II recall D-0018-2025, published October 30, 2024 and initiated September 25, 2024. Recalling firm: Fresenius Kabi Compounding, LLC; Status: Terminated; Reported quantity: 1082 bags; Lot: Lot # C274-000038004, exp. date 27-Nov-24. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

cGMP violations

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Fresenius Kabi Compounding, LLC
Distributor
Product was distributed to 125 direct accounts nationwide.
Lot
Lot # C274-000038004, exp. date 27-Nov-24
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Vancomycin HCl 750 mg per 250 mL 0.9% Sodium Chloride Injection USP, Single Dose Bag, Rx only, Fagron Sterile Services, Canton, MA NDC 71506-014-58 recalled?

Yes. FDA published recall D-0018-2025 on October 30, 2024. Reported hazard: cGMP violations

What should I do if I have this product?

Voluntary: Firm initiated · Letter